黄类化合物作为白血病中的化学敏感剂
Nigar Huseynova1,2, Melisa Çetinkaya3, Züleyha Baran4
1Department of Biophysics and Biochemistry, Baku State University, Baku, Azerbaijan.
Advances in experimental medicine and biology
|November 6, 2024
概括
来自植物的天然化合物黄类化合物通过提高化疗的有效性和潜在地减少副作用,特别是用于白血病治疗,显示出有前途的抗癌药物.
科学领域:
- 植物化学和自然产品
- 瘤学和癌症治疗学 癌症治疗学
- 分子生物学和信号通路
背景情况:
- 黄酸是植物中发现的多种植物营养素,以其抗氧化,抗炎和抗癌特性而闻名.
- 这些天然化合物在调节细胞信号通路方面发挥着重要作用,对于理解它们的治疗潜力至关重要.
- 目前的癌症治疗,包括化疗,往往有显著的副作用,需要探索补充策略.
研究的目的:
- 探索黄类营养保健品作为抗癌剂的潜力,特别是在白血病的背景下.
- 调查黄类药物与传统化疗的整合,以改善癌症治疗结果.
- 了解黄类药物如何影响与癌症治疗相关的细胞信号通路.
主要方法:
- 审查关于黄类生物活性及其在癌症中的作用机制的现有文献.
- 分析黄素在调节癌症进展中涉及的细胞信号通路中的作用.
- 探索黄类药物的化学敏感性质及其提高化疗疗效的潜力.
主要成果:
- 黄类药物通过干扰关键的癌症信号通路和分子来表现出抗癌性质.
- 有证据表明,黄类药物可以作为化学敏感剂,增加癌细胞对化疗的反应能力.
- 黄类药物对癌症治疗方法具有成本效益的前景,可能减少化疗副作用.
结论:
- 将黄类营养药与化疗相结合,为开发新型抗癌疗法,特别是针对白血病提供了一个有前途的战略.
- 对黄类药物和化疗组合的进一步研究可能会提高治疗疗效,降低毒性.
- 黄类化合物是开发具有显著潜在益处的辅助癌症疗法的宝贵领域.
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
149
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
149


